The biosimilar regulatory pathway

Paul Cornes

How is the use of a biosimilar approved? What do regulators look for? How do they guarantee their safety? Paul Cornes, MD from the University Hospital Bristol NHS Foundation Trust, Bristol, UK talks about the biosimilars regulatory pathway.

Share this video  
Similar topics
More from Paul Cornes
Extrapolation - safely approving biosimilars for different indications
Can the dream of affordable cancer care come true?
Can a epoetin biosimilar be used to treat chemotherapy-induced anemia?
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

VJHO needs the contact information you provide to inform you about our latest hemonc news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

The content of VJHemOnc is intended for healthcare professionals